arrow
Back
B

Bohuslav Melichar

university

73H-index
794Paper Count
4.4WCitation Count
Published Papers 174
Publication Date
Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum
err2026-03-02
err0
errOAAI
errOndřej Peterka; Robert Jirásko; Zuzana Dolečková; Mária Dosoudilová; Josef Bártl; Jakub Idkowiak; Ondřej Slavíček; Karolína Pešková; Milan Vošmik; Beatrice Mohelníková-Duchoňová; Irena Kozubíková; Martin Loveček; Ondřej Urban; Jan Trna; Petr Karásek; Bohuslav Melichar; Michal Holčapek
errShare
errSave
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study
err2026-01-08
err0
errOAAI
errThomas Büttner; Mimma Rizzo; Laura Bernal Vaca; Javier Molina-Cerrillo; Teresa Alonso-Gordoa; Alvaro Juárez; Tomas Buchler; Emmanuel Seront; Jakub Kucharz; María Natalia Gandur Quiroga; Maria T. Bourlon; Martin Bögemann; Jindrich Kopecky; Pasquale Rescigno; Ondrej Fiala; Alejo Rodriguez-Vida; Zin W. Myint; Yüksel Ürün; Sarah Scagliarini; Alexandr Poprach; Diana Matthews; Haoran Li; Alessandro Rizzo; Alessandra Mosca; Edoardo Lenci; Bohuslav Melichar; Mike Wenzel; Philipp Mandell; Francesco Massari; Emmanuel S. Antonarakis; Matteo Santoni
errShare
errSave
RP-UHPLC/MS/MS Provides Enhanced Lipidomic Profiling of Human Serum in Pancreatic Cancer
err2025-12-03
err0
PREAI
errZuzana Lásko; Ondřej Peterka; Robert Jirásko; Anna Taylor; Tomáš Hájek; Beatrice Mohelníková-Duchoňová; Martin Loveček; Bohuslav Melichar; Michal Holčapek
errShare
errSave
Benzoyl chloride derivatization improves selectivity and sensitivity of lipidomic quantitation in human serum of pancreatic cancer patients using RP-UHPLC/MS/MS
err2025-10-06
err0
errOAAI
errOndřej Peterka; Zuzana Lásko; Robert Jirásko; Petra Peroutková; Anna Taylor; Beatrice Mohelníková-Duchoňová; Irena Kozubíková; Martin Loveček; Bohuslav Melichar; Michal Holčapek
errShare
errSave
Challenging the dogma: why reviewers should be allowed to use AI tools
err2025-09-01
err0
PREAI
errLippi, Giuseppe; Lackner, Karl J.; Melichar, Bohuslav; Pan, Shiyang; Schlattmann, Peter; Greaves, Ronda; Gillery, Philippe; Plebani, Mario
errShare
errSave
Impact of concomitant use of proton pump inhibitors or cardiovascular medication on survival outcomes of patients with metastatic renal cell carcinoma treated with nivolumab
err2025-08-02
err0
errOAAI
errOndřej Fiala; Petr Hošek; Michaela Tkadlecová; Bohuslav Melichar; Anežka Zemánková; Jindřich Kopecký; Michal Vočka; Martin Matějů; Radka Lohynská; Dominika Šiková; Petr Stránský; Hana Študentová; Martina Spisarová; Hana Nováková; Peter Priester; Dominika Kryštofová; Lucie Grmelová; Tomáš Büchler; Alexandr Poprach
errShare
errSave
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial
err2025-08-01
err0
errOAAI
errBrian I. Rini; Elizabeth R. Plimack; Viktor Stus; Rustem Gafanov; Tom Waddell; Dmitry Nosov; Frédéric Pouliot; Boris Alekseev; Denis Soulières; Bohuslav Melichar; Ihor Vynnychenko; Sergio Jobim de Azevedo; Delphine Borchiellini; Raymond S. McDermott; Jens Bedke; Satoshi Tamada; Sterling Wu; Julia Markensohn; Yiwei Zhang; Andrey Loboda; Amir Vajdi; Rodolfo F. Perini; Joseph Burgents; Thomas Powles
errShare
errSave
Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study
err2025-07-27
err0
errOAAI
errMaria T. Bourlon†; Luca Galli†; Enrique Grande; Se Hoon Park; Bohuslav Melichar; Timothy J. Schieber; Maria José Juan-Fita; Yüksel Ürün; Javier Molina-Cerrillo; Teresa Alonso-Gordoa; Ugo De Giorgi; Jakub Kucharz; Esther Pérez Calabuig; Vincenza Conteduca; Tarek Taha; Pasquale Rescigno; Hussam Abu-Sini; Gian Paolo Spinelli; Ray Manneh Kopp; Alessia Salfi; Dipen Bhuva; Paola Valdez-Sandoval; Sofia Mendez-Bribiesca; Ondrej Fiala; Sebastiano Buti; Fernando Sabino Marques Monteiro; Aristotelis Bamias; Marwan Ghosn; Francesco Massari; Jawaher Ansari‡; Matteo Santoni‡
errShare
errSave
Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study
err2025-06-07
err0
PREAI
errViktor Grünwald; Axel Bex; Sylvie Rottey; Cristina Suárez; Giuseppe Procopio; Guillermo Velasco; Bohuslav Melichar; Jens Bedke; Lisa Pickering; Mário Fontes-Sousa; Manuela Schmidinger; Aristotelis Bamias; Marine Gross-Goupil; Camillo Porta; Philippe Barthélémy; Bernard Escudier; Laurence Albiges
errShare
errSave
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON-1 study
err2025-05-09
err0
errOAAI
errPorta, Camillo; Massari, Francesco; Taha, Tarek; Grande, Enrique; Bourlon, Maria T.; Kanesvaran, Ravindran; Basso, Umberto; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Myint, Zin W.; Fornarini, Giuseppe; Buttner, Thomas; Park, Se Hoon; Urun, Yueksel; De Giorgi, Ugo; Pichler, Renate; Rescigno, Pasquale; Buchler, Tomas; Studentova, Hana; Melichar, Bohuslav; Ansari, Jawaher; Mollica, Veronica; Kucharz, Jakub; Rizzo, Mimma; Rizzo, Alessandro; Kopp, Ray Manneh; Buti, Sebastiano; Monteiro, Fernando Sabino Marques; Soares, Andrey; Bamias, Aristotelis; Santoni, Matteo
errShare
errSave
Pleural effusion as a sample matrix for laboratory analyses in cancer management: a perspective
err2025-03-03
err0
PREAI
errSpisarova, Martina; Studentova, Hana; Hola, Katerina; Melichar, Bohuslav
errShare
errSave
Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02
err2025-03-01
err0
errOAAI
errOaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda
errShare
errSave
Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study
err2025-02-20
err0
errOAAI
errFiala, Ondrej; Buti, Sebastiano; Fujita, Kazutoshi; de Liano, Alfonso Gomez; Fukuokaya, Wataru; Kimura, Takahiro; Yanagisawa, Takafumi; Giannatempo, Patrizia; Angel, Martin; Mennitto, Alessia; Molina-Cerrillo, Javier; Bourlon, Maria T.; Soares, Andrey; Takeshita, Hideki; Calabro, Fabio; Ortega, Cinzia; Kucharz, Jakub; Milella, Michele; Seront, Emmanuel; Park, Se Hoon; Tural, Deniz; Benedetti, Giovanni; Urun, Yuksel; Battelli, Nicola; Melichar, Bohuslav; Poprach, Alexandr; Buchler, Tomas; Kopecky, Jindrich; Conteduca, Vincenza; Monteiro, Fernando Sabino Marques; Massari, Francesco; Gupta, Shilpa; Santoni, Matteo
errShare
errSave
Towards a Consensus on the Management of Metastatic Renal Cell Carcinoma: Insights from a European Delphi Study
err2025-02-08
err0
PREAI
errLaurence Albiges; Marine Gross-Goupil; Philippe Barthélémy; Aristotelis Bamias; Jens Bedke; Axel Bex; Mário Fontes-Sousa; Viktor Grünwald; Bohuslav Melichar; Lisa Pickering; Camillo Porta; Giuseppe Procopio; Sylvie Rottey; Manuela Schmidinger; Cristina Suárez; Guillermo Velasco; Bernard Escudier
errShare
errSave
Case report: Radical robotic nephroureterectomy after chemotherapy followed by avelumab in a patient with node-positive UTUC
err2024-11-11
err0
errOAAI
errStudentova, Hana; Student Jr, Vladimir; Kurfurstova, Daniela; Kopova, Andrea; Melichar, Bohuslav
errShare
errSave
Multi-cancer early detection: searching for evidence
err2024-10-24
err0
errOAAI
errLippi, Giuseppe; Lackner, Karl J.; Melichar, Bohuslav; Schlattmann, Peter; Greaves, Ronda; Gillery, Philippe; Plebani, Mario
errShare
errSave
Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Clinical CA209-9KH Trial
err2024-10-23
err0
errOAAI
errVosmik, Milan; John, Stanislav; Dvorak, Josef; Mohelnikova-Duchonova, Beatrice; Melichar, Bohuslav; Lohynska, Radka; Ryska, Ales; Banni, Aml Mustafa; Krempova, Johana; Sirak, Igor
errShare
errSave
Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02
err2024-09-11
err1
errOAAI
errOaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda
errShare
errSave
CARE1 pragmatic clinical trial: First line randomised study platform to optimize treatment in patients with metastatic renal cell carcinoma
err2024-09-01
err3
PREAI
errAlbiges, L.; Suarez Rodriguez, C.; Procopio, G.; Bex, A.; Gruenwald, V.; Schmidinger, M.; Melichar, B.; De Velasco Oria, G. A.; Bergerot, C. D.; Giles, R.; Woodward, R.; Ferreira, A. R.; Rioux-Leclercq, N.; Bonastre, J.; Claveau, M.; Flippot, R.; Escudier, B.; Foulon, S.; Powles, T. B.
errShare
errSave